U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07106723) titled 'Clinical Study of the Safety and Efficacy of ASCT Combined With CD7-CART in the Treatment of CD7+ TCL' on July 30.
Brief Summary: To evaluate the safety and efficacy of autologous hematopoietic stem cell transfer (ASCT) combined with CD7-CART in the treatment of CD7+ TCL
Study Start Date: June 01
Study Type: INTERVENTIONAL
Condition:
CD7 Positive
T - Cell Lymphoma
Intervention:
DRUG: ASCT+CD7-CART
Intravenous infusion of CD7-CART 3 days after ASCT
Recruitment Status: RECRUITING
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Disclaimer: Curated by HT Syndication....